A polysomnography study of eszopiclone in elderly patients with insomnia

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Medical Research and Opinion

• Publication date

  2006-07-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/030079906X112741PMID 16968566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.

  2005cited by this paper
• A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.

  2005cited by this paper
• Insomnia and Hypnotic Use, Recorded in the Minimum Data Set, as Predictors of Falls and Hip Fractures in Michigan Nursing Homes

  2005cited by this paper
• Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

  2003cited by this paper
• SF-36 health survey: Manual and interpretation guide

  2003cited by this paper
• New developments for treating sleep disorders.

  2001cited by this paper
• Practical Nonparametric Statistics, 3rd Ed.

  2001cited by this paper
• Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

  2001cited by this paper
• Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia

  2000cited by this paper
• Sleep Problems as a Risk Factor for Falls in a Sample of Community‐Dwelling Adults Aged 64–99 years

  2000cited by this paper
• Insomnia in the elderly: a review for the primary care practitioner.

  2000cited by this paper
• The direct economic costs of insomnia in the United States for 1995.

  1999cited by this paper
• Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects.

  1999cited by this paper
• Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.

  1999cited by this paper
• Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II.

  1999cited by this paper
• Nonpharmacological treatment of late-life insomnia.

  1999cited by this paper
• Comprehensive Review of Geriatric Psychiatry-II

  1998cited by this paper
• US Government Printing Office

  1998cited by this paper
• Double‐blind, placebo‐controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia

  1997cited by this paper
• Hypnotic effects of low doses of quazepam in older insomniacs.

  1997cited by this paper
• Sleep complaints among elderly persons: an epidemiologic study of three communities.

  1995cited by this paper
• Management of primary sleep disorders among elderly persons.

  1995cited by this paper
• Management of primary sleep disorders among elderly persons.

  1995cited by this paper
• Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attenders.

  1994cited by this paper
• Established populations for epidemiologic studies of the elderly: Study design and methodology

  1993cited by this paper
• A Double-Blind, Comparative Study of Zolpidem and Placebo in the Treatment of Insomnia in Elderly Psychiatric In-Patients

  1992cited by this paper
• Comprehensive Review of Geriatric Psychiatry

  1991cited by this paper
• Napping and sleep disturbances in the elderly.

  1990cited by this paper
• Morbidity cut-offs for sleep apnea and periodic leg movements in predicting subjective complaints in seniors.

  1990cited by this paper
• Napping and sleep disturbances in the elderly.

  1990cited by this paper
• Efficacy of a reduced triazolam dose in elderly insomniacs.

  1985cited by this paper
• Sleep in older persons: sleep structures of 50- to 60-year-old men and women.

  1982cited by this paper
• Practical Nonparametric Statistics (2nd ed).

  1981cited by this paper
• Practical Nonparametric Statistics

  1972cited by this paper
• A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects.

  1969cited by this paper

• Pharmacologic treatment data from chronic insomnia studies and the application to individuals with acute insomnia, a narrative review.

  2026cites this paper
• Pharmacological and psychological approaches to insomnia treatment in cardiac patients: a narrative literature review

  2025cites this paper
• Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease

  2025cites this paper
• The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials

  2023cites this paper
• Shu-Xie decoction alleviates oxidative stress and colon injury in acute sleep-deprived mice by suppressing p62/KEAP1/NRF2/HO1/NQO1 signaling

  2023cites this paper
• Insomnia in patients with heart disease: A systematic review

  2023cites this paper
• Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis

  2021cites this paper
• Dynamic features of placebo effects addressing persistent insomnia disorder: A meta‐analysis of placebo‐controlled randomized clinical trials

  2020cites this paper
• Comparative Efficacy and Safety of Hypnotics for Insomnia in Older Adults: A Systematic Review and Network Metaanalysis.

  2020cites this paper
• Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly.

  2020cites this paper
• Biphasic Feature of Placebo Response in Primary Insomnia: Pooled Analysis of Data from Randomized Controlled Clinical Trials of Orexin Receptor Antagonists.

  2020cites this paper
• Eszopiclone in the treatment of insomnia

  2020cites this paper
• Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.

  2019cites this paper
• What is “evidence” in psychotherapies?

  2019cites this paper
• Efficacy and Placebo Response of Multimodal Treatments for Primary Insomnia: A Network Meta-Analysis.

  2019cites this paper
• Les médicaments antihistaminiques H1 ont-ils encore une place en 2018 dans le traitement des insomnies ?

  2019cites this paper
• The impact of cognitive behavioural therapy for insomnia on objective sleep parameters: A meta-analysis and systematic review.

  2019cites this paper
• Prospective Randomized Controlled Trial on the Efficacy of Continuous Positive Airway Pressure and Adaptive Servo-Ventilation in the Treatment of Chronic Complex Insomnia

  2019cites this paper
• The assessment and management of insomnia: an update

  2019cites this paper
• Medications That Cause Dry Mouth As an Adverse Effect in Older People: A Systematic Review and Metaanalysis

  2018cites this paper
• The Involvement of 5-HT 2A Receptor in the Regulation of Sleep and Wakefulness, and the Potential Therapeutic Use of Selective 5-HT 2A Receptor Antagonists and Inverse Agonists for the Treatment of an Insomnia Disorder

  2018cites this paper
• South Korean geriatrics on Beers Criteria medications at risk of adverse drug events

  2018cites this paper
• Insomnia in Elderly Patients: Recommendations for Pharmacological Management

  2018cites this paper
• Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline

  2017influential citation
• General Principle of Treatment of Sleep Dysfunction and Pharmacology of Drugs Used in Sleep Disorders

  2017cites this paper
• Review of Safety and Efficacy of Sleep Medicines in Older Adults.

  2016cites this paper
• Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults

  2016cites this paper
• The Effect of Sleep Medication Use and Poor Sleep Quality on Risk of Falls in Community-Dwelling Older Adults in the US: A Prospective Cohort Study

  2016cites this paper
• Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis.

  2015cites this paper
• Non-Benzodiazepine Receptor Agonists for Insomnia.

  2015cites this paper
• Drug Treatment of Sleep Disorders

  2015cites this paper
• Patient Background Factors Affecting the Therapeutic Outcomes in Response to Eszopiclone in Adult Patients with Chronic Insomnia: A Post Hoc Analysis of a Double-Blind Phase III Study in Japan

  2015cites this paper
• Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample

  2015cites this paper
• Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies

  2015cites this paper
• Uso de hipnóticos durante la titulación con presión positiva en la vía aérea superior

  2015cites this paper
• Hypnotics use during the positive airway pressure titration

  2015cites this paper
• Eszopiclone: Review and Clinical Applications in Chronic and Comorbid Insomnia

  2015cites this paper
• Management of Insomnia Disorder

  2015cites this paper
• A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.

  2014cites this paper
• Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials

  2014cites this paper
• An interventional trial to evaluate efficacy of Nutool Therapy in control of Primary insomnia among elderly using Structured Insomnia schedule

  2014cites this paper
• ESZOPICLONE FOR THE TREATMENT OF INSOMNIA IN PATIENTS WITH LOW BACK PAIN A Randomized, Double-Blind, Placebo-Controlled Trial of Eszopiclone for the Treatment of Insomnia in Patients with Chronic Low Back Pain

  2014cites this paper
• Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications.

  2013cites this paper
• Current and Emerging Pharmacotherapies in the Management of Insomnia in Adults

  2013cites this paper
• Eszopiclone for insomnia.

  2013cites this paper
• Insomnia Moderates Outcome of Serotonin-Selective Reuptake Inhibitor Treatment in Depressed Youth

  2012cites this paper
• Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications

  2012cites this paper
• Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study

  2012influential citation
• Pharmacology of Benzodiazepine Receptor Agonist Hypnotics

  2012cites this paper
• Pharmacology of Sleep

  2012cites this paper
• Eszopiclone

  2012cites this paper
• A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.

  2012cites this paper
• Eszopiclone: an update on its use in insomnia.

  2011cites this paper
• Eszopiclone in the Management of Insomnia Among Elderly Patients

  2011cites this paper
• Pharmacological advances in the treatment of insomnia.

  2011cites this paper
• Central nervous system sites of the sleep promoting effects of eszopiclone in rats.

  2011cites this paper
• Management of insomnia in elderly patients using eszopiclone

  2010influential citation
• Clinical Trials and the Development of New Therapeutics for Insomnia

  2010cites this paper
• Persistent Insomnia in Chronic Hypnotic Users Presenting to a Sleep Medical Center: A Retrospective Chart Review of 137 Consecutive Patients

  2010cites this paper
• Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

  2010cites this paper
• Clinical update on nursing home medicine: 2010.

  2010cites this paper
• Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo

  2010cites this paper
• Efficacy and Safety of Zopiclone and Eszopiclone in the Treatment of Primary and Comorbid Insomnia

  2010influential citation
• Pathophysiology of Sleep Disorders

  2010cites this paper
• Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics

  2010cites this paper
• A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.

  2010cites this paper
• Benzodiazepine Receptor Agonists: Indications, Efficacy, and Outcome

  2010cites this paper
• Insomnia and chronic heart failure

  2009cites this paper
• Sleep disorders: impact on daytime functioning and quality of life

  2009cites this paper
• Comparative Tolerability of Newer Agents for Insomnia

  2009cites this paper
• Insomnia: A Review of the Use of eszopiclone

  2009cites this paper
• New Paradigms in Comorbid Insomnia Funding

  2009cites this paper
• The role of eszopiclone in the treatment of insomnia

  2009cites this paper
• Late-life comorbid insomnia: diagnosis and treatment.

  2009cites this paper
• A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice.

  2009cites this paper
• Hur inverkar sömnmedel i form av bensodiazepiner och bensodiazepinbesläktade medel på dagtrötthet och frakturrisk hos äldre

  2008cites this paper
• Pharmacotherapy for insomnia.

  2008cites this paper
• Sleep and Its Disorders in Seniors.

  2008cites this paper
• Pharmacologic treatment of disturbed sleep in the elderly.

  2008cites this paper
• APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia.

  2008cites this paper
• Next‐day cognition, psychomotor function, and driving‐related skills following nighttime administration of eszopiclone

  2008cites this paper
• Pharmacotherapy of insomnia

  2008cites this paper
• Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.

  2008cites this paper
• Spotlight on Eszopiclone in Insomnia

  2008cites this paper
• Clinical Medicine Insights: Geriatrics

  2008cites this paper
• Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.

  2008cites this paper
• Pharmacotherapy of insomnia

  2008cites this paper
• Managing Insomnia in Older People

  2007cites this paper
• Treating the health, quality of life, and functional impairments in insomnia.

  2007cites this paper
• Eszopiclone: a nonbenzodiazepine that effectively improves sleep maintenance and initiation in patients with insomnia

  2007cites this paper
• Eszopiclone: its use in the treatment of insomnia

  2007cites this paper
• Intensive session: New approaches to medical issues in long-term care.

  2007cites this paper
• Current awareness in human psychopharmacology

  2007cites this paper
• Cost–effectiveness of eszopiclone for the treatment of chronic insomnia

  2007cites this paper